Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism—the Tromsø study

Abstract

Background Chronic obstructive pulmonary disease (COPD) is associated with risk of venous thromboembolism (VTE). It remains unknown whether individual respiratory symptoms and lowered oxygen saturation (SpO2), individually and in combination with COPD, affect the risk of VTE. Objectives To investigate whether measures of respiratory impairments including respiratory symptoms and SpO2, individually and combined with COPD, were associated with an increased risk of VTE. Methods Spirometry, SpO2, and self‐reported respiratory symptoms were collected in 8686 participants from the fifth (2001‐2002) and sixth (2007‐2008) surveys of the Tromsø Study. Incident VTE events were registered from the date of inclusion to December 31, 2016. Cox regression models with exposures and confounders as time‐varying covariates (for repeated measurements) were used to estimate hazard ratios (HRs) with 95% confidence intervals (CIs) for VTE. Results During a median follow‐up of 9.1 years, 330 participants developed incident VTE. Subjects with SpO2 ≤ 96% (lowest 20th percentile) had a 1.5‐fold higher risk of VTE (adjusted HR, 1.48; 95% CI, 1.13‐1.93) compared with those with SpO2 ≥ 98%. Severe respiratory symptoms (dyspnea, cough, and phlegm) were associated with a 1.4‐ to 2.0‐fold higher risk of VTE compared with no such symptoms. COPD, combined with respiratory symptoms or lowered SpO2, had an additive effect on the VTE risk. Conclusions Lowered SpO2 and severe respiratory symptoms were associated with increased VTE risk. COPD combined with respiratory impairments had an additive effect on VTE risk, and may suggest particular attention on VTE preventive strategies in COPD patients with respiratory impairments.

Room to Breathe: The Impact of Oxygen Rationing on Health Outcomes in SARS-CoV2

“…In the acute setting, hypoxia increases the risk of fatal arrhythmia and end-organ damage (26). In a subacute setting, hypoxia has been shown to drive pulmonary inflammation and the systemic inflammatory response (27,28) and to promote coagulation leading to an increase in thromboembolic events (29,30). Long-term effects of hypoxia include ongoing cognitive impairment (31).…”

Rational Use of Oxygen in COVID-19 Pandemic – Are We Doing Enough?

“…Medical literature has abundant reports of complications of acute hypoxia such as fatal arrhythmia, increased risk of the systemic inflammatory response, and end-organ damage. [11][12][13] However, recent evidence also suggests that liberal oxygen therapy in acutely ill adults is associated with increased in-hospital mortality. 14 There is also a robust association between arterial hyperoxia and increased mortality in patients admitted to intensive care units.…”

Pulmonary Artery Thrombosis: A Diagnosis That Strives for Its Independence

“…However, follow-up of these patients for 7 days and 3 months showed that rethrombosis in the territory of the PA (without DVT), which predominates in this type of patients, is of greater importance in the structure of recurrent VTE and mortality [ 7 , 8 ]. Analysis of exacerbations of COPD showed that low SpO 2 values, dyspnea, and disease severity increase the risk of PA thrombosis [ 9 ]. Studies evaluating incidences of local PA thrombosis separately from DVT+PE reported its development in 5–39% of patients with COPD [ 10 , 11 ].…”